Skip to main content

CivaTech’s Radiation Device Tested in First Pancreatic Cancer Patient

A Virginia man has become the first person in the world to be treated for pancreatic cancer with a bio-absorbable, implantable radiation device called CivaSheet, developed by Durham-based CivaTech Oncology.

 

Merz Reports Positive Test Results for Neurotoxin Drug

Merz Neurosciences, a division of Raleigh-based Merz North America, has reported positive results from a Phase 3 clinical trial of its drug Xeomin for the treatment of adult sialorrhea, or unwanted drooling, due to Parkinson’s disease and other neurologic disorders.

Bioventus Surgical Broadens Offerings with Big Healthcare Alliance

In a big win for its surgical business, Durham-based Bioventus says all of its surgical orthobiologics products are now available through Premier Inc., a large group purchasing organization consisting of 3,750 U.S. hospitals and more than 130,000 other healthcare providers.

Walkers, Runners Needed for Nutrition, Exercise Study in Kannapolis

Appalachian State University’s Human Performance Laboratory on the N.C. Research Campus (NCRC) is recruiting at least 30 more male and female walkers and runners this month to determine if a 45-minute walk has the same effect on the digestion and circulation of healthful flavonoids as a 2.5-hour run.

Chiltern Acquires Japanese CRO for Greater Asian Presence

Chiltern, a global contract research organization (CRO) with U.S. headquarters in Wilmington, has acquired Integrated Development Associates Co. Ltd. (IDA), a Japanese CRO that specializes in integrating Japan and Asia into global drug development.

Grifols’ Zika Test Available for Blood Screening in Europe

A test for screening blood donations for presence of the Zika virus is now being sold in Europe by Grifols, a global developer of plasma-derived medicines that has 2,500 employees in North Carolina.

Liquidia’s Opioid Alternative Fares Well in Phase 1 Trial

Morrisville-based Liquidia Technologies has reported positive initial results from a phase 1 clinical trial of a drug candidate for relieving post-surgery pain as an alternative to addictive opioids.

Ag Biotech Summit 2018

Tuesday, February 20, 2018 11:00am

 

Pages

Subscribe to RSS - Life Sciences